Avestar Capital, LLC Eli Lilly & CO Transaction History

Avestar Capital, LLC

$951 Million
Q3 2024

A detailed history of Avestar Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Avestar Capital, LLC holds 5,886 shares of LLY stock, worth $4.52 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

5,886

Previous 500 1077.2%

Holding current value

$4.52 Million

Previous $452,000 1053.54%

% of portfolio

0.55%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $557,485 - $693,134	722 Added 13.98%	5,886 $5.21 Million
Q2 2024 Aug 08, 2024	BUY	$724.87 - $909.04 $603,816 - $757,230	833 Added 19.23%	5,164 $4.68 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $473,167 - $633,031	799 Added 22.62%	4,331 $3.37 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $329,819 - $388,813	628 Added 21.63%	3,532 $2.06 Million
Q3 2023 Oct 20, 2023	BUY	$434.7 - $599.3 $233,868 - $322,423	538 Added 22.74%	2,904 $1.56 Million
Q2 2023 Aug 01, 2023	BUY	$350.74 - $468.98 $169,407 - $226,517	483 Added 25.65%	2,366 $1.11 Million
Q1 2023 Apr 20, 2023	SELL	$310.63 - $364.82 $9,629 - $11,309	-31 Reduced 1.62%	1,883 $646,000
Q4 2022 Jan 20, 2023	BUY	$321.55 - $374.67 $62,702 - $73,060	195 Added 11.34%	1,914 $0
Q3 2022 Oct 26, 2022	BUY	$296.48 - $337.87 $181,445 - $206,776	612 Added 55.28%	1,719 $556,000
Q2 2022 Jul 28, 2022	BUY	$278.73 - $327.27 $64,386 - $75,599	231 Added 26.37%	1,107 $359,000
Q1 2022 Apr 26, 2022	BUY	$234.69 - $291.66 $30,040 - $37,332	128 Added 17.11%	876 $251,000
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $168,187 - $208,721	748 New	748 $207,000
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $46,667 - $50,761	-437 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$110.79 - $129.32 $2,215 - $2,586	-20 Reduced 4.38%	437 $43,000
Q1 2019 May 09, 2019	BUY	$111.31 - $131.02 $111 - $131	1 Added 0.22%	457 $55,000
Q4 2018 Jan 25, 2019	BUY	$105.9 - $118.64 $529 - $593	5 Added 1.11%	456 $48,000
Q3 2018 Oct 23, 2018	SELL	$85.86 - $107.31 $6,954 - $8,692	-81 Reduced 15.23%	451 $45,000
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $1,665 - $1,911	-22 Reduced 3.97%	532 $41,000
Q1 2018 May 10, 2018	SELL	$74.21 - $87.6 $49,794 - $58,779	-671 Reduced 54.78%	554 $36,000
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $100,376 - $107,665	1,225	1,225 $100,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.

Account

Avestar Capital, LLC Eli Lilly & CO Transaction History